INVO Bioscience elects board members
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
INVO Bioscience Inc. elected Michael Campbell and Stephen Shum to its board, increasing the number of directors to five from three.
Campbell serves as the vice president of IVF Americas at Cooper Surgical, a unit of Cooper Cos. Inc.
Shum serves as CFO of Eastside Distilling Inc.
